Filing Details
- Accession Number:
- 0001019687-13-000245
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-24 11:30:15
- Reporting Period:
- 2013-01-22
- Filing Date:
- 2013-01-24
- Accepted Time:
- 2013-01-24 11:30:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1355790 | International Stem Cell Corp | ISCO | Pharmaceutical Preparations (2834) | 204494098 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1447708 | Andrey Semechkin | 5950 Priestly Drive Carlsbad CA 92008 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-22 | 10,000,000 | $0.20 | 12,037,800 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-01-22 | 8,000,000 | $0.25 | 8,000,000 | No | 4 | C | Indirect | By Corp. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Indirect | By Corp. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant (Right to Buy) | Acquisiton | 2013-01-22 | 5,000,000 | $0.00 | 5,000,000 | $0.20 |
| Common Stock | Series C Preferred Stock | Acquisiton | 2013-01-22 | 2,000,000 | $0.00 | 8,000,000 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000,000 | 2013-01-22 | 2018-01-22 | No | 4 | P | Direct |
| 0 | No | 4 | C | Indirect |
Footnotes
- The Series C Preferred Stock was owned by X-Master, Inc., a New Hampshire corporation of which the reporting person is a director and the sole shareholder.
- The Series C Preferred Stock was convertible into common stock at any time at a conversion rate of $0.25 per share, and had no expiration date.
Billionaire Hedge Funds
